Stock Information
Halozyme Therapeutics Inc (HALO)
Ticker Symbol: HALO
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $8,176.52 mil
Piotroski score: 5
PE Ratio: 25.4887
EPS (TTM): 2.4916
Revenue (TTM): $11.87 M
Dividend Yield: N/A%
ROE: 92.67%
Latest News
-
Halozyme Therapeutics, Inc. (HALO) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Tue, Mar 3, 2026 8:52 PM
-
Is Halozyme Therapeutics (HALO) a Buy Post Earnings?
Sun, Mar 1, 2026 9:27 AM
-
Halozyme Therapeutics, Inc. (HALO): A Bull Case Theory
Sat, Feb 28, 2026 4:54 PM
-
2 Reasons to Like HALO (and 1 Not So Much)
Wed, Feb 25, 2026 1:36 PM
-
Halozyme to Participate in Upcoming Investor Conferences
Wed, Feb 25, 2026 1:30 PM
Key Financials
Financial data not available
